Findings

What do systematic reviews say?

4,929 questions · 15,174 findings · 2,372 reviews

Sort:Best matchNewestHighest certainty Download CSV

No studies found 15,174 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Silicone gel sheeting vs non‐silicone gel sheeting treatment

Adherence · people with keloid scars

The review found no eligible studies for this question.

1 finding from 1 review

Silicone gel sheeting for treating keloid scars 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Silicone gel sheeting vs non‐silicone gel sheeting treatment

Health‐related quality of life · people with keloid scars

The review found no eligible studies for this question.

1 finding from 1 review

Silicone gel sheeting for treating keloid scars 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Silicone gel sheeting vs intralesional injections of triamcinolone acetonide

Scar severity validated by participants · people with keloid scars

The review found no eligible studies for this question.

1 finding from 1 review

Silicone gel sheeting for treating keloid scars 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Silicone gel sheeting vs intralesional injections of triamcinolone acetonide

Adverse events · people with keloid scars

The review found no eligible studies for this question.

1 finding from 1 review

Silicone gel sheeting for treating keloid scars 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Silicone gel sheeting vs intralesional injections of triamcinolone acetonide

Adherence · people with keloid scars

The review found no eligible studies for this question.

1 finding from 1 review

Silicone gel sheeting for treating keloid scars 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Silicone gel sheeting vs intralesional injections of triamcinolone acetonide

Health‐related quality of life · people with keloid scars

The review found no eligible studies for this question.

1 finding from 1 review

Silicone gel sheeting for treating keloid scars 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Silicone gel sheeting vs no treatment

Scar severity validated by participants · people with keloid scars

The review found no eligible studies for this question.

1 finding from 1 review

Silicone gel sheeting for treating keloid scars 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Silicone gel sheeting vs no treatment

Adverse events · people with keloid scars

The review found no eligible studies for this question.

1 finding from 1 review

Silicone gel sheeting for treating keloid scars 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Silicone gel sheeting vs no treatment

Adherence · people with keloid scars

The review found no eligible studies for this question.

1 finding from 1 review

Silicone gel sheeting for treating keloid scars 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Silicone gel sheeting vs no treatment

Health‐related quality of life · people with keloid scars

The review found no eligible studies for this question.

1 finding from 1 review

Silicone gel sheeting for treating keloid scars 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Silicone gel sheeting vs non‐silicone gel sheeting treatment

Scar severity validated by participants · people with keloid scars

The review found no eligible studies for this question.

1 finding from 1 review

Silicone gel sheeting for treating keloid scars 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Silicone gel sheeting vs non‐silicone gel sheeting treatment

Adverse events · people with keloid scars

The review found no eligible studies for this question.

1 finding from 1 review

Silicone gel sheeting for treating keloid scars 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Olokizumab vs placebo or usual care

Clinical improvement D60 or more ‐ not reported · people with mild/moderate/severe/critical COVID‐19

The review found no eligible studies for this question.

1 finding from 1 review

Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Olokizumab vs placebo or usual care

WHO progression score (level 7 or above) D28 ‐ not reported · people with mild/moderate/severe/critical COVID‐19

The review found no eligible studies for this question.

1 finding from 1 review

Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Olokizumab vs placebo or usual care

All‐cause mortality D60 or more · people with mild/moderate/severe/critical COVID‐19

The review found no eligible studies for this question.

1 finding from 1 review

Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Olokizumab vs placebo or usual care

Adverse events ‐ not reported · people with mild/moderate/severe/critical COVID‐19

The review found no eligible studies for this question.

1 finding from 1 review

Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Siltuximab vs placebo or usual care

Clinical improvement D60 or more ‐ not reported · people with mild/moderate/severe/critical COVID‐19

The review found no eligible studies for this question.

1 finding from 1 review

Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Siltuximab vs placebo or usual care

Adverse events ‐ not reported · people with mild/moderate/severe/critical COVID‐19

The review found no eligible studies for this question.

1 finding from 1 review

Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Levilimab vs placebo or usual care

Clinical improvement D60 or more ‐ not reported · people with mild/moderate/severe/critical COVID‐19

The review found no eligible studies for this question.

1 finding from 1 review

Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Levilimab vs placebo or usual care

WHO progression score (level 7 or above) D28 ‐ not reported · people with mild/moderate/severe/critical COVID‐19

The review found no eligible studies for this question.

1 finding from 1 review

Interleukin‐6 blocking agents for treating COVID‐19: a living systematic review 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found